← AI Companies
Oscar Health is a technology-driven health insurance company that uses AI and data science to simplify insurance, personalize care, and improve healthcare outcomes.
- Share Price
- 33.47USD
- Market Cap
- 10.40BUSD
- Revenue
- 17.47BUSD
- Net Income
- 855.47MUSD
- P/E (trailing)
- 14.9x
Financial data: Yahoo Finance, as of 11-Nov-2026
Price & Size
| Price |
33.47 USD |
| Market Cap |
10.40B USD |
| Shares Outstanding |
275.51M |
| Shares Float |
265.66M |
| 52w Low |
10.69 USD |
| 52w High |
38.50 USD |
| Avg Volume |
5.37M |
Valuation
| P/E (trailing) |
14.9x |
| P/E (forward) |
14.5x |
| P/B |
4.67x |
| Enterprise Value |
3.38B USD |
| Book Value / Share |
7.16 USD |
| P/S |
0.60x |
| EV / Revenue |
0.19x |
| EV / EBITDA |
3.51x |
Income
| Revenue |
17.47B USD |
| Revenue / Share |
58.58 USD |
| EBITDA |
964.46M USD |
| Net Income |
855.47M USD |
| EPS (trailing) |
2.25 USD |
| EPS (forward) |
2.31 USD |
Margins & Profitability
| Gross Margin |
20.6% |
| Operating Margin |
3.5% |
| Profit Margin |
4.9% |
| EBITDA Margin |
5.5% |
| Return on Equity |
52.6% |
| Return on Assets |
7.4% |
Cash & Debt
| Total Cash |
7.49B USD |
| Total Debt |
481.73M USD |
| Free Cash Flow |
1.73B USD |
| Operating Cash Flow |
4.18B USD |
| Debt / Equity |
0.22x |
| Current Ratio |
1.14x |
| Quick Ratio |
1.09x |
Dividend
| Yield |
0.0% |
| Payout Ratio |
0.0% |
Analyst Consensus
| Target (Mean) |
37.00 USD |
| Target (Median) |
35.50 USD |
| Target (High) |
49.00 USD |
| Target (Low) |
27.00 USD |
| Analysts' Rating |
Hold |
| # Analysts |
10 |
Sentiment 58.0%
as of 11-Nov-2026
Sentiment is an AI (Grok) reading of market mood over the past 30 days: 0% very negative, 50% neutral, 100% very positive.
Positive drivers
Oscar Health's AI-driven underwriting tools contributed to stronger-than-expected membership growth during the period. Strategic tech partnerships announced in October 2026 improved platform scalability and attracted positive analyst commentary. Q3 results highlighted efficiency gains from machine learning in claims processing.
Neutral / mixed
Broader healthcare sector volatility and macroeconomic factors created mixed trading patterns for OSCR. Regulatory developments around AI usage in insurance remained in discussion without immediate impact. Stock performance tracked closely with peer health insurers amid stable enrollment trends.
Negative drivers
Rising medical loss ratios pressured margins and raised profitability concerns among investors. Increased competition from larger insurers weighed on market share expectations. Lingering questions about long-term AI ROI in healthcare tempered enthusiasm.
Bottom line
Sentiment for OSCR is moderately positive overall, supported by AI advancements but offset by operational and competitive headwinds.
NYSE
USD